releases: https://harshbarger.house.gov/media/press-releases/harshbarger-colleagues-introduce-right-try-individualized-treatments-act
Data license: MIT · Data source: dwillis/congress-press
This data as json
| url | title | date | year | month | party | chamber | state | member_name | bioguide_id | domain | scraper | source | date_source | text | has_text | collected_at | updated_at |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| https://harshbarger.house.gov/media/press-releases/harshbarger-colleagues-introduce-right-try-individualized-treatments-act | Harshbarger, Colleagues Introduce Right to Try for Individualized Treatments Act | 2026-06-08 | 2026 | 2026-06 | Republican | House | TN | Diana Harshbarger | H001086 | harshbarger.house.gov | harshbarger | https://harshbarger.house.gov/media/press-releases | scraper | “When someone is fighting for their life, the last thing they need is the government standing in their way,” said Congresswoman Diana Harshbarger. “We are entering a new era of medicine where breakthroughs in genomics and precision therapies can create treatments designed specifically for an individual patient, but our regulatory system was built for a different time and simply hasn't kept up. This legislation makes sure patients have a clear, durable path to pursue individualized treatments when all other options have failed.” “One of my first efforts upon taking office in January 2017 was to partner with Senator Ron Johnson to champion Right to Try, which we passed through both the U.S. House and Senate. Many of us know people who are terminally ill and desperately seeking to extend their lives. Right to Try gives these individuals hope, freedom, and power to try potentially life-saving drug therapies. Our coalition was unwilling to let one more American die without this chance, and we are motivated to build on this original bill with the Right to Try for Individualized Treatments Act. I am honored to again help lead this bill in the U.S. House, and I pray we can quickly send it to President Trump's desk to be enacted into law,” said Congressman Andy Biggs. “I championed Right to Try to provide hope and freedom to those with terminal illnesses by giving them access to experimental treatments without waiting for full FDA approval. The original Right to Try Act was about giving terminal patients a fighting chance by cutting through red tape,” saidSenator Ron Johnson. “Right to Try 2.0 builds on that success and would provide access to individualized, rare disease and one-patient therapies that the current regulatory environment has yet to accommodate. This is about medical freedom and putting doctors and patients at the top of the treatment pyramid.” “Patients battling serious and life-threatening diseases too often reach a devastating dead end: no approved treatments left, and nowhere else to turn. The Right to Try for Individualized Treatments Act changes that by giving these patients and their doctors the ability to pursue promising, individualized therapies while preserving strong transparency and safety guardrails. This legislation is a critical breakthrough that ensures medical innovation doesn’t stop at the FDA’s door—it reaches the patients who need it most after conventional options have failed. We are deeply grateful to Reps. Harshbarger and Biggs and Senator Johnson for championing this patient-first approach. They are helping restore hope, agency, and dignity to families facing the hardest moments of their lives by putting them back in the driver’s seat of their own care,” said Terry Wilcox, Co-Founder & CEO of Patients Rising. | 1 | 2026-06-27T21:44:12Z | 2026-06-27T22:11:26Z |